Key facts
- This page summarizes Kevin G. Byrnes's Form 4 filing for MEDIFAST INC (MED).
- 7 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 15 Nov 2021, 19:10.
Kevin G. Byrnes - 11 Nov 2021 Form 4 Insider Report for MEDIFAST INC (MED)
- Reporting relationship
- Director
- Issuer ticker
- MED
- Reported as of
- 11 Nov 2021
- Net transaction value
- -$1,031,230
- SEC form
- 4
- Accepted by SEC
- 15 Nov 2021, 19:10:34 UTC
- Prior SEC filing
- 24 Aug 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Jason L. Groves, attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Kevin G. Byrnes filed Form 4 for MEDIFAST INC (MED) on 15 Nov 2021.
Change
- Previous filing in this sequence was filed on 24 Aug 2021.
- Current net transaction value: -$1,031,230.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MED
transaction
Common Stock
Options Exercise
- Transaction value
- $77,359
- Shares
- +2,917
- Change %
- +36%
- Price
- $26.52
- Shares after
- 11,071
- Date
- 11 Nov 2021
- Ownership
- Direct
MED
transaction
Common Stock
Options Exercise
- Transaction value
- $157,750
- Shares
- +5,000
- Change %
- +45%
- Price
- $31.55
- Shares after
- 16,071
- Date
- 11 Nov 2021
- Ownership
- Direct
MED
transaction
Common Stock
Options Exercise
- Transaction value
- $138,400
- Shares
- +5,000
- Change %
- +31%
- Price
- $27.68
- Shares after
- 21,071
- Date
- 11 Nov 2021
- Ownership
- Direct
MED
transaction
Common Stock
Tax liability
- Transaction value
- $1,404,739
- Shares
- -6,149
- Change %
- -29%
- Price
- $228.45
- Shares after
- 14,922
- Date
- 11 Nov 2021
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
MED
transaction
Derivative
Stock Options
Options Exercise
- Transaction value
- $0
- Shares
- -2,917
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 11 Nov 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,917
- Exercise price
- $26.52
- Footnotes
- F2
MED
transaction
Derivative
Stock Options
Options Exercise
- Transaction value
- $0
- Shares
- -5,000
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 11 Nov 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 5,000
- Exercise price
- $31.55
- Footnotes
- F3
MED
transaction
Derivative
Stock Options
Options Exercise
- Transaction value
- $0
- Shares
- -5,000
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 11 Nov 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 5,000
- Exercise price
- $27.68
- Footnotes
- F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
Represents a withholding of 6,149 shares of the Issuer's common stock to satisfy the exercise price and the tax obligation in connection with the exercise of certain stock options.
Footnote F2
These options vested in three equal annual installments beginning on February 5, 2015.
Footnote F3
These options vested in three equal annual installments beginning on February 17, 2016.
Footnote F4
These options vested in three equal annual installments beginning on February 4, 2017.